Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 26 P357

ECE2011 Poster Presentations Steroid metabolism (10 abstracts)

Inhibitory effect of glucocorticoids on GLUT4 expression in visceral adipose tissue may be determined by increased 11β hydroxysteroid dehydrogenase 1 (11β-HSD1) expression

R C T Mori , R S Campello & U F Machado


Institute of Biomedical Sciences, Sao Paulo, SP, Brazil.


Local glucocorticoids action depends on 11β hydroxysteroid dehydrogenase (11β-HSD) enzymes. Adipose tissues mainly express the 11β-HSD1, which activates inactive cortisone. Altered 11β-HSD1 and GLUT4 expressions have been reported in obesity. GLUT4 participates in the genesis and maintenance of insulin resistance/obesity, and could also be involved in the insulin resistant state observed in hypercortisolism. The aim of this study was to investigate the 11β-HSD1 and GLUT4 expressions in visceral (VAT) and subcutaneous (SAT) adipose tissues of insulin resistant, hypercorticosteronemic MSG-obese rats, considering the tissue-specific action of glucocorticoids.

Methods: Male Wistar rats (C) were rendered obese (O), by neonatal treatment with monosodium glutamate (4 mg/g per day). Insulin tolerance tests (ITT), plasma insulin and corticosterone confirmed the obesity features. GLUT4 and 11β-HSD1 mRNAs were analyzed in VAT and SAT, by northern blotting and RT-PCR respectively. Sterol regulatory element binding protein-1c (SREBP-1c) expression and binding activity were also investigated.

Results: Obese rats were hyperinsulinemic (O=61.4±5.0 μU/ml, P<0.05 vs C=40.1±5.5 μU/ml), hypercorticosteronemic (O=168.3±9.5 ng/ml P<0.001 vs C=80.3±9.8 ng/ml) and insulin resistant (kITT=3.42%/min, P<0.01 vs C: 5.06%/min). GLUT4 mRNA was decreased in obese VAT (O=80.9±3.8 UA, P<0.01 vs C=100.2±4.2 UA), where 11β-HSD1 mRNA was increased (O=142.5±6.9 UA, P<0.01 vs C=100.0±5.8 UA). On the contrary, in obese SAT GLUT4 mRNA was increased (O=122.1±9.4 UA, P<0.05 vs C=100.0±5.3 UA) while 11β-HSD1 was decreased (O=78.0±7.5 UA, P<0.05 vs C=100.0±5.2 UA). SREBP1-c binding activity to GLUT4 promoter sequence was unaltered. However, SREBP-1c expression was significantly lower in obese VAT (O=82.0±4.0 UA, P<0.05 vs C=100.0±4.4), remaining unchanged in obese SAT (O=94.8±3.2 UA, P<0.05 vs C=100.0±6.3 UA).

Conclusion: Data suggest an inhibitory effect of glucocorticoids on GLUT4 gene expression in VAT, determined by a higher expression of the 11β-HSD1 enzyme. This effect may involve mechanisms at transcriptional level, since the expression of SREBP1-c, a transcriptional factor known to increase GLUT4 gene transcription, was shown to be decreased in VAT. Financial support: 07/59722-4.

Article tools

My recent searches

No recent searches.